MedTrace Logo

A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults

NCT04209647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-07-30

No results posted yet for this study

Summary

Exercise is a key component of obesity management. Obese subjects cannot attend or sustain exercise program because of increased general fatigue, dyspnea and muscle fatigue. And they feel more exertion when comparing with normal weight subjects. Reduced-exertion high-intensity interval training (REHIT) is a alternative method to continuous exercise programs. The investigators aimed comparing metabolic effects of REHIT and continuous exercise in young adults, in this study.

Conditions

  • Obesity
  • Exercise
  • Oxygen Consumption

Interventions

OTHER

REHIT Exercise

-Start with warm-up period --\> %50 of maximum work rate, 3 minutes One Exercise Cycle consists of: * 15 seconds exercise period: %100 of maximum work rate * 15 seconds recovery period: %50 of maximum work rate Total Duration: 10 minutes

OTHER

Continuous Aerobic Exercise

At %50 of maximum heart rate, 30-60 minutes aerobic exercise

Sponsors & Collaborators

  • Istinye University

    lead OTHER

Principal Investigators

  • Nurgul Durustkan Elbasi, PhD · Istinye University

  • Yunus Emre Tutuneken, PT · Istinye University

  • Yasemin Cirak, Ass Prof · Istınye U

  • Duygu Korkem, PhD · University of Health science

  • Beyza Karaduz, MsC · Hacettepe University

  • Ebru Calik Kutukcu, PhD · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
22 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-04-01
Completion
2019-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04209647 on ClinicalTrials.gov